Signaling Pathways - Vascular Disrupting Agents (VDA) - DOT1L - CRM1 - AXL
清除全部
- B5940 TP-0903中文名: 度博替尼Target: AXLSummary: AXL受体酪氨酸激酶抑制剂,抗癌药
- B1581 EPZ004777 HClTarget: DOT1LSummary: DOT1L抑制剂
- B1463 KPT-276Target: nuclear export|CRM1Summary: CRM1抑制剂
- B2298 Plinabulin (NPI-2358)中文名: 普那布林Target: Vascular Disrupting Agents (VDA)Summary: 血管破坏剂
- A4170 EPZ004777Target: DOT1LSummary: DOT1L抑制剂
- A4166 EPZ56761 CitationTarget: DOT1LSummary: DOT1L抑制剂